marginal significancep = 0.051
37 , 38 Moreover, variant carriers with AD exhibited higher levels of pTau217 with marginal significance ( p = 0.051; Figure 3E ), and higher levels of biomarkers indicating increased inflammation (i.e., CHI3L1, CCL13, IL33, and IL17A) compared to non‐carriers with AD.